Elanco Animal Health Incorporated (ELAN) Revenue-to-Profit Sankey Flow & SEC XBRL Financials
Elanco Animal Health Incorporated (ELAN) carries a Roarable Rating of C (Hold) with 63/100 RQD Confidence. The underlying business is intact, so current owners don’t need to panic-sell—but mixed big-money flow or rich pricing means new buyers can afford to wait for either a pullback or a B-or-higher upgrade.
How ELAN Turns Every Dollar of Sales Into Real Bottom-Line Profit
Multi-Year SEC EDGAR XBRL Revenue, Net Profit & Free Cash Flow Trajectory
| Fiscal Year | Revenue | Gross Margin | Op Margin | Net Profit | Free Cash Flow | ROIC % |
|---|---|---|---|---|---|---|
| FY 2025 | $4.71B | 55% | -5.8% | -$232.0M | $284.0M | -2.4% |
| FY 2024 | $4.44B | 54.9% | 9% | $338.0M | $394.0M | 3.2% |
| FY 2023 | $4.42B | 44% | -32.9% | -$1.23B | $72.2M | -29.8% |
Red-Light Warning Desk: How Pros Profit When Overhyped Stocks Crack (Featuring ELAN)
- ✓Live walkthrough of ELAN's RQD Radar, SEC cash-conversion gap & downside levels
- ✓3 asymmetric Bear/Hedge setups institutions use when 10-year yields stay elevated
- ✓Includes instant 24/7 email alert whenever any of your stocks flip to Red
ELAN Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +6.2% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on ELAN today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for ELAN. Explore sector supply chains on /butterfly.
ELAN Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDHow profitable is Elanco Animal Health Incorporated (ELAN)?
In FY 2025 (10-K), ELAN converted $4.7B of revenue into a 55% gross margin, 0% operating margin, and $284.0M in free cash flow (6% FCF margin).